Latest news with #woundcare
Yahoo
6 days ago
- Health
- Yahoo
How to Care for Cuts, Scrapes, and Stitches in Kids
A Pediatrician's Guide to Wound Care, Healing, and When to See a Doctor It's natural to feel a pit in your stomach when your child gets hurt, whether it's a scraped knee from a playground tumble or a cut that makes your heart race a little. Knowing what to do in the moment can help your child heal faster, stay infection-free, and even reduce the chance of scarring. Types of Wounds in Children First, let's break down what kind of wound you're dealing with. The two most common are abrasions (aka scrapes) and lacerations (aka cuts). Abrasions happen when the skin gets scraped against something rough, think tripping on the sidewalk or sliding on concrete. These usually aren't deep but can cover a large area. Lacerations are deeper cuts that break through more layers of skin. These can come from sharp edges, broken glass, or a fall with impact. Some lacerations can be handled at home, but others need medical closure like stitches, staples, or dermabond (medical glue). Does my child's cut need medical attention? While many minor cuts can be treated at home, some wounds need medical closure. This is especially important to prevent infection, speed healing, and minimize scarring. Here's when to get your child's wound checked out: The wound is deep, with edges that stay apart even when you press them together. It was a deep puncture wound (such as stepping on a nail). Bleeding doesn't stop after five minutes of direct pressure. The wound is over a joint or a high-tension area (elbows, knees, etc.) The cut is on the face, particularly near the lips or eyes. A human or animal bite caused the wound and broke the skin You cannot get the wound clean and still see significant debris inside Wound closure options If your clinician recommends closing the wound, they'll consider the size, depth, location, and how clean it is. The main closure methods are: Dermabond (medical glue): A go-to for clean, small cuts, especially on the face or upper body. It's fast, painless, and less scary for kids. But it can't be used in high-moisture spots, over joints, or near the eyes. Stitches: Best for longer or jagged cuts and areas that move a lot. The area is numbed before stitches go in. Some are dissolvable; others need to be removed later. Staples: Often used for the scalp or thick-skinned areas. Quick and strong—but they'll need to be removed after 7–10 days. How to care for wounds at home Even if the wound doesn't need stitches, how you treat it at home really matters. Here's a simple, clear routine: Step 1: Stop the bleeding. Use clean gauze or a towel and apply pressure until bleeding slows. If it hasn't stopped after 5 minutes, check in with your child's provider. Step 2: Clean it gently. Skip the hydrogen peroxide, it kills healthy cells, not just bacteria. Use mild soap and lukewarm water, then pat dry with a clean towel. Step 3: Follow specific care instructions. For dermabond: keep the area dry for 24 hours, and let the glue fall off on its own. For stitches or staples: keep it clean and dry the first day, then follow your provider's directions. Keep the area covered and avoid soaking. Step 4: Moisturize the wound. This surprises a lot of people, but petroleum jelly like Vaseline or Aquaphor helps keep the wound moist and prevents scabbing. A moist wound heals faster and reduces scarring. Step 5: Go easy on antibiotic ointments. Neosporin is everywhere, but it can cause allergic reactions due to neomycin. Ask your pediatrician if Bacitracin is a safer option for your child. Step 6: Keep it covered. A clean, non-stick bandage protects the wound from germs. Just make sure it's not too tight, you want good circulation. Bonus: fun, colorful bandages can make it less scary for your child. Reducing the risk of scarring One common concern for parents is how to prevent scarring after their child's injury. While it's nearly impossible to avoid scarring entirely, there are a few steps you can to take to reduce its appearance. Keep the wound moist. Petroleum jelly is your best friend here. Silicone sheets (like ScarAway) can help reduce visible scars once the skin is closed. Check the label for age guidelines and usage instructions. Sun protection is key. UV rays can darken scars, especially on new skin. Keep it covered or use a kid-safe sunscreen. Remind your child not to pick. Scabs can be tempting little targets. Bandages and rewards help keep little hands away. Signs of infection: when to call your child's clinician Most wounds start to look better every day. If things are going the other direction, such as becoming more red, swollen, or painful, it's time to call in backup. Watch for: Redness, swelling, or increasing pain, especially after day 2 Warm skin around the wound Pus or unusual drainage Fever or feeling unwell Red streaks moving away from the cut The bottom line Accidents and injuries are a part of childhood, but with the right care, your child's wound can heal properly with minimal scarring. Knowing when to seek medical attention, how to care for wounds, and the most common mistakes to avoid can help you feel prepared to care for your child's wound. Check out the PedDocTalk YouTube video on wound care for more tips on wound healing, including what to expect from a visit to the clinician for a wound and how to reduce scarring. Remember, your child's clinician is always a resource if you have any concerns or questions about wound care.
Yahoo
15-07-2025
- Business
- Yahoo
Merakris Therapeutics Selected as Finalist for 2025 Advanced Would Care Summit Innovation Showcase
MTX-001, an investigational new drug, aims to become the first subcutaneous biologic drug therapy for chronic non-healing venous leg ulcers RESEARCH TRIANGLE PARK, N.C., July 15, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics announces its amniotic fluid-derived regenerative biologic, MTX-001, an investigational new drug, is a finalist for the Innovation Showcase: Early-Stage Disruptors in Wound Care at the 2025 Advanced Wound Care (AWC) Summit in Boston. Only six companies were chosen by the AWC selection committee to present at the event on July 17, 2025 at 8:30am ET. At the Innovation Showcase, Chris Broderick, Merakris Therapeutics CEO, will present an overview of MTX-001, including promising key findings from the ongoing Phase 2 clinical trial evaluating the therapy in patients with non-healing venous leg ulcers (VLUs) also referred to as venous stasis ulcers (VSUs). 'Non-healing VLUs affect millions of people and a substantial number of patients fail to heal with today's standard therapies,' said Broderick. 'MTX-001 represents a new class of regenerative biologics delivered via subcutaneous injection. This innovation is proving to promote healing in chronic venous wounds and improve patient outcomes.' Also at the 2025 Advanced Wound Care Summit, Sean O'Connell, PhD, Head of Medical Affairs at Merakris Therapeutics, will present 'Injectable Drugs as the Next Big Step for Advanced Wound Care' on July 16th at 3:15pm. His talk will review the MTX-001 clinical program, interim Phase 2 results, and outline upcoming plans for a Phase 3 clinical trial. He will also highlight the unmet needs in the chronic wound market and the emerging role of injectable biologics in outpatient care. For strategic partnership and collaboration opportunities, please visit For more information about the MTX-001 clinical trial or Merakris' Expanded Access Program, please contact medaffairs@ About Merakris Therapeutics Merakris Therapeutics is a leading innovator in regenerative medicine focused on developing and commercializing biologically derived products for wound healing and other complex conditions. Leveraging advanced biologic manufacturing capabilities and a robust research pipeline, Merakris is committed to improving patient outcomes and advancing the science of regenerative therapies. Merakris Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the marketing and other potential of Merakris' products, or regarding potential future revenues from any such product. Forward-looking statements are generally identified by the words 'expects', 'anticipates', 'believes', 'intends', 'estimates', 'plans' and similar expressions. Although Merakris' management believes that any forward-looking statements in this press release are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Merakris, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, unexpected regulatory actions or delays, or government regulation generally, that could affect the availability or commercial potential of the product, the fact that product may not be commercially successful, the uncertainties inherent in research and development, including future clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general, risks associated with intellectual property and any related future litigation and the ultimate outcome of such litigation, and volatile economic and market conditions may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and advisors and on the global economy as a whole. Investigational drug tradename (Dermacyte Liquid or Dermacyte Amniotic Wound Care Liquid) has not been approved by FDA. CONTACT: PR Contact: Garth Miller Nova Marketing Solutions 919-923-3505Sign in to access your portfolio
Yahoo
14-07-2025
- Business
- Yahoo
Kane Biotech to Present at Advanced Wound Care Summit USA
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) ('Kane Biotech' or 'Kane') announces today that Kane Biotech's Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the 4th Advanced Wound Care Summit USA taking place from July 15-17, 2025 in Boston, MA. The Advanced Wound Care Summit USA is an industry gathering dedicated to the business of wound care where innovators, payers, regulators, and multinational leaders come together to turn breakthrough science into profitable, accessible therapies. Dr. Huizinga's presentation will be available on Kane's website as of July 16, 2025. About Kane Biotech Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds which results in serious clinical outcomes and significant cost. revyve™ addresses both biofilms and wound bacteria. For more information: Dr. Robert Huizinga Ray Dupuis Interim CEO Chief Financial Officer Kane Biotech Inc Kane Biotech Inc rhuizinga@ rdupuis@ (780) 970-1100 (204) 298-2200 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking InformationThis press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management's current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company's: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at The Company cautions that the foregoing list of factors that may affect future results is not al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
Yahoo
11-07-2025
- Health
- Yahoo
The First Aid Kit Items Everyone Should Always Keep Stocked, According to Doctors
You probably have a first aid kit sitting under your bathroom sink or in your medicine cabinet that's been there for a while. That tiny box probably has a few bandages, ibuprofen, and maybe even an ice pack. But in a true emergency, a small piece of gauze and an expired ointment packet might not be enough. So, what should you really have in your first aid kit? Spoiler alert: probably a lot more than you realize. 'A well-stocked first aid kit can be a real lifesaver, one that transforms a standard cabinet into a lifesaving command center," says Ramón Tallaj, MD, an internist and chairman of SOMOS Community Care in New York City. "Focus on layering capability, monitoring data, and comfort or support.' Here, doctors share exactly what you need to keep in your first aid kit so you're always prepared. Related: Only Prime Members Can Score These Just-Dropped Deals From Kate Spade, Ninja, Bissell, Dyson, and More—From $8 Wound care essentials are probably the most important thing to keep in your first aid kit. Dr. Tallaj suggests stocking the following in case of an unexpected cut, scrape, or wound. Adhesive bandages in various sizes and butterfly strips Sterile gauze pads and adhesive tape Antiseptic solution and wipes Antibiotic ointment (such as Neosporin) Hemostatic dressing (such as QuikClot) A tourniquet You might not think about leaving a pair of gloves and a set of tweezers (not the ones you use for your eyebrows) in your first aid kit, but these are must-haves. 'For everything from splinters to wound care, gloves protect both you and the person you're helping,' says Scottsdale-based naturopath Sabrina Solt. Even if you don't think you need these special-scenario items, you probably don't want to be caught without them because they could save the life of a friend or family member, according to Dr. Tallaj. EpiPen Asthma inhaler Glucose gel/tablets and honey sticks Antiemetic (ondansetron) and anti-diarrheal Tick-removal tool Burn gel packets Both professionals recommend stashing electrolyte packets in your first aid kit. 'Electrolytes are essential for hydration support, especially during illness, travel, or heat exposure," says Solt. "Look for ones without artificial dyes or sweeteners." A fever isn't just the sign of illness like the flu—it can also indicate your body is fighting off an infection, and a thermometer will help you gauge just how serious it is. 'You'd be surprised how often these simple tools give early insight into infection or inflammation before symptoms escalate,' Solt says. Dr. Tallaj says it's a smart Idea to have pain, fever, and neurological relief medications on hand. This includes: Acetaminophen and ibuprofen Oral antihistamines (diphenhydramine) Migraine-specific meds (sumatriptan or Ubrevely) Cooling gel eye mask Pain relief cold/hot packs Muscle cramps can be incredibly painful and ruin your day, but a quick dose of magnesium can get your body to relax. 'Magnesium helps with muscle cramps, headaches, and nervous system regulation," Solt says. "Transdermal magnesium is an underrated first-aid essential." While the pandemic is over, it's still best to take precautions if someone in your home has COVID or is suspected to be ill. That's why Dr. Tallaj recommends keeping PPE in your kit. Disposable surgical masks N95 respirators Hand sanitizer Alcohol prep pads Read the original article on Real Simple
Associated Press
07-07-2025
- Health
- Associated Press
Real-world evidence study uses SnapshotNIR on 4,000+ wounds to deliver targeted care and improve wound healing outcomes
The retrospective study examines SnapshotNIR use on wounds in post-acute care, showing how tissue viability insights help improve plan of care for patients. 'Our pioneering, big data research in post-acute care settings using this point-of-care diagnostic technology enabled our providers to utilize data-driven decisions rather than relying on assumptions.'— Martha R. Kelso, RN, CHWS, DAPWCA, HBOT CALGARY, ALBERTA, CANADA, July 7, 2025 / / -- Kent Imaging, a leader in near-infrared spectroscopy (NIRS) medical imaging, is proud to share the publication in the Journal of Wound Care titled 'Utilization of Near Infrared Spectroscopy (NIRS) in Post-Acute Care: Analysis of Real-World Clinical Decision Making.' This is a pioneering study reporting real-world evidence of a data set of 19,192 wounds from 6,147 patients in post-acute care. The study provided the most comprehensive real-world evaluation of SnapshotNIR, analyzing its clinical application across 35% of the dataset, in 2,165 patients, and 4,060 wounds. The data highlighted how numerous providers, across 22 states of the US, selectively deployed SnapshotNIR in cases of clinical complexity, particularly when conventional wound care approaches had plateaued. SnapshotNIR directly impacted clinician's care plans for the imaged wounds including determining a wound goal as maintenance (20.76%), noting a wound goal as healable (17.39%), identifying the need for additional studies (11.60%), determining a wound goal as palliative (5.22%), and directing hospice referral (0.76%). The study found that providers used SnapshotNIR for care plan evaluation (92.98%), tissue oxygenation trending (66.65%), evaluation of the necessity and effectiveness of debridement (29.16%), and microcirculation or vascular referral assessment (8.89%). The NIRS-imaged group included patients with non-healing wounds, systemic disease burden, and vascular risk factors—populations in whom diagnostic uncertainty is high, and healing trajectories are difficult to predict. Martha R. Kelso, RN, CHWS, DAPWCA, Founder and Chief Regulatory Officer at Wound Care Plus, LLC, and primary author stated, 'Our pioneering, big data research in post-acute care settings using this point-of-care diagnostic technology enabled our providers to utilize data-driven decisions rather than relying on assumptions. Using SnapshotNIR as our premier choice for near-infrared spectroscopy has provided valuable insights into tissue perfusion beyond the limits of the naked eye with the wound and skin surface. Additionally, with Kent Imaging's SnapshotNIR, we can see inflammatory processes, oxygenation, and deoxygenation, helping us to confirm or change wound etiology in real-time without a care delay. This diagnostic device showed we could perform higher-quality debridements by getting down to viable tissue with adequate perfusion—a key step in wound healing. With visual NIR guidance, the clinicians at Wound Care Plus, LLC can perform diagnostics, debride, and perform other procedures with confidence, helping to heal more wounds more effectively.' 'SnapshotNIR has become an essential part of my daily workflow as a wound care clinician,' commented Erin Brunkan, FNP-C at Wound Care Plus LLC, and a co-author. She continued, 'It's like having a window into a wound's healing potential. Our goal is always to do our best clinical work to close a wound, and this publication highlighted how objective data from the device can drive a wound towards closure, with more confidence and clarity in our plan of care.' SnapshotNIR uses NIRS to assess tissue oxygenation by measuring the relative concentrations of oxygenated and deoxygenated hemoglobin within the microvasculature. This non-invasive, handheld imaging technology delivers instant, color-coded oxygenation maps assisting clinicians in their treatment planning. Unique to SnapshotNIR is the hemoglobin view, providing clinicians with additional insights into wound healing trends without the need for dyes, contact, or compression, at the point of care. Kelso added, 'Wound Care Plus, LLC adopted this technology company-wide in 2022 when these portable diagnostic devices passed our 'trunk-to-bed' test. A requirement I use to invest in diagnostic technologies is being able to take them right to the patient's bedside—meeting our need to facilitate on-the-spot assessments for perfusion. This data shows we are making a significant difference, healing more wounds, and providing appropriate certified plans of care to meet this underserved population. In Post-Acute Care, technology and advancements are often anemic or an afterthought by payors, despite being the demographic that needs it the most due to significant co-morbidities, polypharmacy, and a host of other challenges. This technology brings the diagnostic side of wound care out of the 1980s and into the millennia where we belong.' The study's results validated the targeted use of SnapshotNIR in a diverse patient population. It demonstrated healing rates of 36.5% for pressure ulcers, 38.15% for lower extremity wounds, and 39.68% for all wounds, compared to the previously published healing rate of 22.5% for the same practice when using standard of care. It represented an improvement of 62%–76% in healing rates compared to the previously published rate. 'The data showed that even in complex cases, we were able to shift wound goals from palliative to healable in numerous cases, which is a game-changer for the population we treat across the country,' noted Amanda R. Ohrt, MHA, AAPWCA, Chief Quality Officer at Wound Care Plus LLC, and co-author. 'For our mobile care patients, where every visit counts, SnapshotNIR gives us the insights we need to tailor treatments that actually work, allowing us to heal more wounds.' As this technology continues to gain traction in acute, post-acute, and outpatient settings, Kent Imaging remains committed to supporting ongoing research and provider education. Congratulations to the team of clinicians and researchers behind this publication. Special recognition to lead author Martha R. Kelso, RN, CHWS, DAPWCA, HBOT, and co-authors Amanda R. Ohrt, MHA, AAPWCA; Erin Brunkan, NP-C; Denise Flynn, AGNP-C; Lauren Riley, FNP-C; William H. Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA; Najratun Nayem Pinky, PhD; Debarpan Das, MSc; Jeffrey Niezgoda, MD, FACHM, MAPWCA, CHWS; and Jennie Feight, MS, CPC, CPMA, CPC-I. About Kent Imaging Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in near-infrared tissue oxygenation imaging, which develops, manufactures, and markets medical technology that supports real-time decision-making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. SnapshotNIR is supported by clinical evidence demonstrating its ability to help improve clinical decision-making in wound care and reduce healing time. Since receiving FDA and Health Canada clearance in 2017, the technology has been featured in several published articles and peer-reviewed posters. Applying the knowledge gained from clinical trials to patient care promotes consistency of treatment and optimal outcomes. Leah Pavlick Kent Imaging Inc. [email protected] Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
